PEOPLE TAKING GLP-1S have a reduced risk of heart attacks, strokes, and death from cardiovascular disease, according to a ...

It's not just celebrities and TikTok creators jumping on the weight loss drug hype - more than 500,000 people in the UK are ...

Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been ap ...

with the potential for a 15% weight loss after 68 weeks in adults with a BMI of 30 or greater [1]. Like Ozempic, Wegovy is also prescription only and taken once a week. Saxenda, like Ozempic and ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

Losing weight by dieting (restricting energy) includes, along with fat loss, losing lean mass, about half of which is ...

Marketed as Ozempic, Wegovy or Saxenda, these drugs are administered via a weekly injection that mimics GLP-1 - a hormone ...

This is why Saxenda and similar weight loss injections today must meet strict regulatory standards before going to market. The FDA approved Bontril PDM (phendimetrazine tartrate) in 1976 for the ...

Ozempic 3.0? Retatrutide — an experimental drug nicknamed “triple G” — could be your best shot at a slimmer waistline when it ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Surgery is the gold standard, GLP-1s are all the rage—whether a head-to-head study is needed depends on who you ask.